Imprimer la page

Towards Elimination of Malaria in Tanzania (TEMT)


Despite significant progress, Tanzania is still a major malaria-burdened country. It aspires to further accelerate progress towards malaria elimination through innovative strategies and investments in research, vaccine development, and multi-country collaborations. Switzerland supports capacity building, evidence creation, systems to strengthen vector control, case management, surveillance, monitoring and evaluation, multi-sectoral collaboration and cross-border initiatives upon request by the Government.

Pays/région Thème Période Budget
Tanzanie
Santé
Gouvernance
nothemedefined
Paludisme
Renforcement des systèmes de santé
Politique du secteur publique
01.05.2025 - 30.04.2030
 CHF  5’900’000
Le projet en bref
Contexte Over the past two decades, Tanzania has strengthened its public health infrastructure and community initiatives like distributing insecticidetreated bednets, thus reducing malaria transmission. From 2015 to 2020, under-five malaria prevalence fell from 14% to 8.1%, under-five mortality from 67 to 43 per 1,000 live births, annual in-patient facility cases from 7.7 to 5.9 million, and malaria incidence from 162 to 106 per 1,000 people. Despite progress, challenges like drug and insecticide resistance as well as climate-driven outbreaks persist, requiring further innovations, better resource mobilization, and sustained political commitment. TEMT supports the National Malaria Control Program (NMCP) and the Zanzibar Malaria Elimination Program (ZAMEP) with targeted technical assistance for strategic malaria interventions under the respective Ministries of Health.
Objectifs To contribute to the reduction of malaria morbidity and mortality in Tanzania Mainland and malaria elimination in Zanzibar in line with the respective strategic plans.
Groupes cibles

For disease burden: Tanzania’s population of ~70 million

For systems and skills: Ministries of Health - Mainland and Zanzibar (specifically, NMCP and ZAMEP); President’s Office Regional Administration and Local Government (PO-RALG); Zanzibar!President’s Office – Regional Administration and Special Departments (PO-RASD).
Effets à moyen terme

Outcome 1: Strengthened evidencebased strategies and innovative surveillance-response efforts for malaria control and elimination

Outcome 2: Enhanced Multi-sectoral engagement and coordination for sustainable malaria control and elimination.
Résultats

Principaux résultats attendus:  

  1. 233 additional shehias1 (n=388, from 58 to 291) achieving zero local malaria transmission in Zanzibar
  2. 20 additional councils (n=184, from 70 to 90) achieving low malaria transmission risk status in Tanzania mainland
  3. At least 8 non-health sectors (n=27) implementing and documenting-malaria smart activities in 15 high burden mainland councils (n=57)
  4. At least 10 regional and global scientific publications on the Tanzanian malaria experience


Principaux résultats antérieurs:  

  1. National level: Introduced targeted planning based on microstratification, structured engagement of sectors beyond health, and multi-country cross-border joint control efforts
  2. In high burden strata: A 53% reduction in malaria prevalence among school-aged children through generation of evidence-based strategies for preventive treatment
  3. In moderate-risk strata: A 53% reduction in the malaria positivity rate among pregnant women 
  4. In low-risk strata: A 31% decrease in malaria incidence among individuals aged 5+ through application of biolarvicides
  5. Bolstered NMCP and ZAMEP to raise resources leveraging CHF 83 for every CHF 1 invested by Switzerland
Direction/office fédéral responsable DDC
Partenaire de projet Partenaire contractuel
Secteur privé
Institution universitaire et de recherche suisse
  • Sectreur privé étranger Sud/Est
  • Swiss Tropical and Public Health Institute


Coordination avec d'autres projets et acteurs The Ifakara Health Institute (IHI); the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM); the U.S. President's Malaria Initiative (PMI); the Gates Foundation (GF); the East African Community’s Great Lakes Malaria Initiative (EAC’s GLMI); the RBM Partnership to End Malaria (formerly, the Roll Back Malaria Partnership); the African Leaders Malaria Alliance (ALMA).
Budget Phase en cours Budget de la Suisse CHF    5’900’000 Budget suisse déjà attribué CHF    0 Budget y compris partenaires de projet CHF    858’800’000 Projet total depuis la première phase Budget de la Suisse CHF   6’463’515 Budget y compris partenaires de projet CHF   19’594’771
Phases du projet Phase 2 01.05.2025 - 30.04.2030   (Phase en cours) Phase 1 01.12.2018 - 30.04.2025   (Completed)
  • Secteur selon catégorisation du Comité d'aide au développement de l'OCDE SANTE
    SANTE
    GOUVERNEMENT ET SOCIETE CIVILE
    Sous-Secteur selon catégorisation du Comité d'aide au développement de l'OCDE
    Lutte contre le paludisme
    Politique de la santé et gestion administrative
    Politiques publiques et gestion administrative
    Thème transversal Le projet est axé sur l'amélioration du fonctionnement de l'organisation partenaire
    Type d'aide Mandat avec gestion de fonds
    Mandat sans gestion de fonds
    Numéro de projet

    7F10130

Début de la page
Dernière mise à jour 23.01.2025